Focal liver lesions in oncology;Lésions hépatiques en cancérologie générale

Journal de Radiologie

Volumn 88, Issue 7-8 C2, 2007, Pages 1091-1103

  Menu, Y ^a   Bessoud, B ^a   Rocher, L ^a   Lesavre, A ^a   Phan, C ^a   Rangheard, A S ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Liver, neoplasms

Indexed keywords

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; DIAGNOSTIC IMAGING; ECHOTOMOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER CANCER; LIVER INJURY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODENSITOMETRY; RADIOLOGIST; REVIEW; TUMOR BIOPSY;

EID: 34547678176     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(07)89921-5     Document Type: Article

References (35)

1. Bipat S, van Leeuwen MS, Ijzermans JN, Bossuyt PM, Greve JW, Stoker J. Imaging and treatment of patients with colorectal liver metastases in the Netherlands:a survey. Neth J Med 2006;64:147-151.
2. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology 2005;237:123-131.
3. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002;224:748-756.
4. Silvera L, Galula G, Tiret E, Louvet C, Leroux JL, Trutt B. Assessment of management practices for colonic cancer in the Paris metropolitan area in 2002. Gastroenterol Clin Biol 2006;30:852-858.
5. Zieren HU, Muller JM, Zieren J, Pichlmaier H. The impact of patient's age on surgical therapy of colorectal liver metastases. Int Surg 1993;78:288-291.
6. Hao CY, Ji JF. Surgical treatment of liver metastases of colorectal cancer:Strategies and controversies in 2006. European Journal of Surgical Oncology 2006;32:473-483.
7. Lin JT, Wang WS, Yen CC, Liu JH, Yang MH, Chao TC, Chen PM, Chiou TJ. Outcome of colorectal carcinoma in patients under 40 years of age. J Gastroenterol Hepatol 2005;20:900-905.
8. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006;243:373-379.
9. d'Annibale M, Piovanello P, Cerasoli V, Campioni N. Liver metastases from breast cancer:the role of surgical treatment. Hepatogastroenterology 2005;52:1858-1862.
10. Bipat S, Phoa SS, van Delden OM, Bossuyt PM, Gouma DJ, Lameris JS, Stoker J. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma:a meta-analysis. J Comput Assist Tomogr 2005;29:438-445.
11. Swanson DA. Surgery for metastases of renal cell carcinoma. Scand J Surg 2004;93:150-155.
12. Modlin IM, Latich I, Kidd M, Zikusoka M, Eick G. Therapeutic options for gastrointestinal carcinoids. Clin Gastroenterol Hepatol 2006;4:526-547.
13. Benoist S, Brouquet A, Penna C, Julie C, El Hajjam M, Chagnon S, Mitry E, Rougier P, Nordlinger B. Complete response of colorectal liver metastases after chemotherapy:does it mean cure? J Clin Oncol 2006;24:3939-3945.
14. Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. J Clin Oncol 2004;22:4753-4761.
15. Khalil HI, Patterson SA, Panicek DM. Hepatic lesions deemed too small to characterize at CT:prevalence and importance in women with breast cancer. Radiology 2005;235:872-878.
16. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999;210:71-74.
17. Krakora GA, Coakley FV, Williams G, Yeh BM, Breiman RS, Qayyum A. Small hypoattenuating hepatic lesions at contrast-enhanced CT:prognostic importance in patients with breast cancer. Radiology 2004;233:667-673.
18. Holalkere NS, Sahani DV, Blake MA, Halpern EF, Hahn PF, Mueller PR. Characterization of small liver lesions:Added role of MR after MDCT. J Comput Assist Tomogr 2006;30:591-596.
19. Reimer P, Jahnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N, Saini S. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000;217:152-158.
20. Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM. Hepatocellular carcinoma in patients with chronic liver disease:comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2005;238:531-541.
21. Kim KW, Kim AY, Kim TK, Park SH, Kim HJ, Lee YK, Park MS, Ha HK, Kim PN, Kim JC, Lee MG. Small (l.e. 2cm) Hepatic lesions in colorectal cancer patients:detection and characterization on mangafodipir trisodium-enhanced MRI. Am. J. Roentgenol. 2004;182:1233-1240.
22. Kim YK, Lee JM, Kim CS, Chung GH, Kim CY, Kim IH. Detection of liver metastases:gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 2005;15:220-228.
23. Kim MJ, Kim JH, Lim JS, Oh YT, Chung JJ, Choi JS, Lee WJ, Kim KW. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. Journal of Magnetic Resonance Imaging 2004;20:612-621.
24. Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, Motoori K, Ueda T. Hepatic metastases:diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006;239:122-130.
25. Onishi H, Murakami T, Kim T, Hori M, Iannaccone R, Kuwabara M, Abe H, Nakata S, Osuga K, Tomoda K, Passariello R, Nakamura H. Hepatic metastases:detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006;239:131-138.
26. Ward J, Robinson PJ, Guthrie JA, Downing S, Wilson D, Lodge JP, Prasad KR, Toogood GJ, Wyatt JI. Liver metastases in candidates for hepatic resection:comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 2005; 237:170-180.
27. Terkivatan T, van den Bos IC, Hussain SM, Wielopolski PA, de Man RA, IJzermans JN. Focal nodular hyperplasia:lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study. Journal of Magnetic Resonance Imaging 2006;24:864-872.
28. Truant S, Huglo D, Hebbar M, Ernst O, Steinling M, Pruvot FR. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 2005;92:362-369.
29. Therasse P, Eisenhauer E. Confirmation of response in cancer clinical trials:A meaningless exercise? European Journal of Cancer 2005;41:1501-1502.
30. Therasse P, Le Cesne A, Van Glabbeke M, Verweij J, Judson I. RECIST vs. WHO:Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. European Journal of Cancer 2005;41:1426-1430.
31. Therasse P, Eisenhauer EA, Verweij J. RECIST revisited:a review of validation studies on tumour assessment. European Journal of Cancer 2006;42:1031-1039.
32. Trillet-Lenoir V, Freyer G, Kaemmerlen P, Fond A, Pellet O, Lombard-Bohas C, Gaudin JL, Lledo G, Mackiewicz R, Gouttebel MC, Moindrot H, Boyer JD, Chassignol L, Stremsdoerfer N, Desseigne F, Moreau JM, Hedelius F, Moraillon A, Chapuis F, Bleuse JP, Barbier Y, Heilmann MO, Valette PJ. Assessment of tumour response to chemotherapy for metastatic colorectal cancer:accuracy of the RECIST criteria. Br J Radiol 2002;75:903-908.
33. de Bazelaire C, Rofsky NM, Duhamel G, Zhang J, Michaelson MD, George D, Alsop DC. Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. Eur Radiol 2006;16:2083-2091.
34. Cuenod CA, Fournier L, Balvay D, Guinebretiere JM. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 2006;31:188-193.
35. Barrett T, Kobayashi H, Brechbiel M, Choyke PL. Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol 2006;60:353-366.